Rights and permissions
About this article
Cite this article
ACE inhibitors not worth it as first-line therapy in hypertension. Pharmacoecon. Outcomes News 413, 5 (2003). https://doi.org/10.1007/BF03276268
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276268